4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-012052
CFO and Treasurer sold 50,000 shares at an average $65.09 ($3,254,710)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krognes Steve E. CFO and Treasurer | 2021-02-16 | Sale | −22,684 | $64.27 | $1,457,923 | 927,316 | I |
| Krognes Steve E. CFO and Treasurer | 2021-02-16 | Sale | −10,199 | $65.04 | $663,323 | 917,117 | I |
| Krognes Steve E. CFO and Treasurer | 2021-02-16 | Sale | −16,616 | $66.20 | $1,099,996 | 900,501 | I |
| Krognes Steve E. CFO and Treasurer | 2021-02-16 | Sale | −501 | $66.80 | $33,468 | 900,000 | I |
| Open-market sales · 50,000 sh · avg $65.09 · $3,254,710 | |||||||
Loading xslF345X03/doc4.xml…